Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The feasibility of a set of physical resilience measurements in older patients admitted to the acute medical unit.

BMC geriatrics·2025
Same author

Incidence, symptom clusters and determinants of post-acute COVID symptoms: a population-based surveillance in community-dwelling users of the COVID RADAR app.

BMJ open·2024
Same author

Predicting whether patients in an acute medical unit are physiologically fit-for-discharge using machine learning: A proof-of-concept.

International journal of medical informatics·2024
Same author

Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?

Expert review of pharmacoeconomics & outcomes research·2023
Same author

Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes.

Journal of thrombosis and haemostasis : JTH·2018
Same author

High risk of recurrent venous thrombosis in patients with lower-leg cast immobilization.

Journal of thrombosis and haemostasis : JTH·2018

Related Experiment Video

Updated: Jul 13, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

Venous thrombosis in the elderly.

F R Rosendaal1, A VAN Hylckama Vlieg, C J M Doggen

  • 1Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands. f.r.rosendaal@lumc.nl

Journal of Thrombosis and Haemostasis : JTH
|August 1, 2007
PubMed
Summary

Elderly individuals face a higher risk of venous thrombosis and bleeding during anticoagulant therapy. Research indicates both environmental factors and coagulation system abnormalities contribute significantly to thrombosis in older adults.

Related Experiment Videos

Last Updated: Jul 13, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

Area of Science:

  • Gerontology
  • Hematology
  • Thrombosis Research

Background:

  • Venous thrombosis incidence is 1-2 per 1000 person-years overall, but approaches 1% annually in the very elderly.
  • The elderly with thrombosis exhibit high case-fatality rates, exacerbated by cancer and age-dependent risks of major hemorrhage during anticoagulation.
  • Despite increased vulnerability, research on venous thrombosis etiology and treatment in the elderly is less extensive compared to younger populations.

Purpose of the Study:

  • To review the current understanding of venous thrombosis in the elderly.
  • To highlight the roles of environmental factors and coagulation system abnormalities in geriatric thrombosis.
  • To emphasize the need for increased research focus on thrombosis in older adults.

Main Methods:

  • Comprehensive literature review on venous thrombosis in the elderly.
  • Analysis of new data from the MEGA-study.
  • Discussion of etiological factors including environmental risks and coagulation system abnormalities.

Main Results:

  • Environmental risk factors like immobilization and cancer are significant contributors to thrombosis in the elderly.
  • Abnormalities within the coagulation system are equally or more critical in causing thrombosis in older individuals compared to younger ones.
  • The risk of major hemorrhage during anticoagulant therapy is strongly age-dependent, increasing elderly patient vulnerability.

Conclusions:

  • Thrombosis in the elderly is a critical issue influenced by both external factors and intrinsic coagulation system changes.
  • Further research specifically targeting the elderly population is essential for improving the diagnosis and management of venous thrombosis.
  • Future studies should prioritize understanding and addressing the unique aspects of thrombosis in older adults.